IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,637 | -99.9% | 267,997 | +92.2% | 0.02% | +42.9% |
| Q3 2022 | $1,336,000 | -62.3% | 139,467 | -34.5% | 0.01% | -44.0% |
| Q1 2022 | $3,546,000 | +183.7% | 212,974 | +225.1% | 0.02% | +257.1% |
| Q4 2021 | $1,250,000 | -29.3% | 65,514 | -8.6% | 0.01% | -36.4% |
| Q3 2021 | $1,768,000 | -52.9% | 71,704 | -11.4% | 0.01% | -85.5% |
| Q4 2020 | $3,756,000 | +22.1% | 80,965 | -27.8% | 0.08% | -17.4% |
| Q2 2020 | $3,077,000 | – | 112,098 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |